Literature DB >> 26432656

Prognostic factors in spinal chordoma: A systematic review.

Ming-Xiang Zou1, Wei Huang2, Xiao-Bin Wang1, Jing Li3, Guo-Hua Lv1, You-Wen Deng1.   

Abstract

OBJECTIVE: Discovering reliable prognostic factors for spinal chordoma remains a challenge. We attempted to identify evidence-based prognostic factors in the literature since its inception and to establish pooled relative risks (RR) of such factors.
METHODS: MEDLINE and Embase search (inception to December 2014). Two reviewers independently selected papers involving spinal chordoma prognostic factors, and studied them for methodological quality and valuable new factors. Subsequently, we attempted to pool the results.
RESULTS: Of 1465 citations, we studied 65 papers closely, and found several "new" prognostic factors. However, only eight papers were of adequate quality for analysis. Location in the upper cervical spine (pooled RR=5.46, 95% confidence interval [CI]: 2.23-13.34), worse preoperative Frankel score (pooled RR=2.77, 95% CI: 1.73-4.42), intralesional surgery (pooled RR=2.68, 95% CI: 1.66-4.32), greater extent of invasion (pooled RR=5.09, 95% CI: 1.49-17.41), and revision surgery (pooled RR=2.42, 95% CI: 1.34-4.36) appeared to be independent factors for worse outcome.
CONCLUSIONS: Despite the wealth of literature available, disappointingly few papers are of sufficient quality for drawing valid conclusions related to spinal chordoma prognostic factors. The heterogeneity of the studies renders results pooling almost impossible. More accurate individual prognostication requires methodologically high-quality studies with more uniform study design and data reporting.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chordoma; Factors; Humans; Prognosis; Spine; Survival analysis

Mesh:

Year:  2015        PMID: 26432656     DOI: 10.1016/j.clineuro.2015.09.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.

Authors:  Ming-Xiang Zou; Guo-Hua Lv; Jing Li; Xiao-Ling She; Yi Jiang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Recurrent L3 Chordoma Presented as Intradural Extramedullary Mass With Distant Metastasis: A Case Report.

Authors:  Soo Jin Jang; Nayoung Han; Eun Kyeong Hong; Ho-Shin Gwak
Journal:  Brain Tumor Res Treat       Date:  2022-04

3.  Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis.

Authors:  Ming-Xiang Zou; An-Bo Peng; Guo-Hua Lv; Xiao-Bin Wang; Jing Li; Xiao-Ling She; Yi Jiang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

4.  Cervical chordomas: multicenter case series and meta-analysis.

Authors:  Oluwaseun O Akinduro; Diogo P Garcia; Ricardo A Domingo; Tito Vivas-Buitrago; Bernardo Sousa-Pinto; Mohamad Bydon; Michelle J Clarke; Ziya L Gokaslan; Maziyar A Kalani; Kingsley Abode-Iyamah; Alfredo Quiñones-Hinojosa
Journal:  J Neurooncol       Date:  2021-04-03       Impact factor: 4.130

5.  Differences in sex distribution, anatomic location and MR imaging appearance of pediatric compared to adult chordomas.

Authors:  Ronnie Sebro; Thomas DeLaney; Francis Hornicek; Joseph Schwab; Edwin Choy; G Petur Nielsen; Daniel I Rosenthal
Journal:  BMC Med Imaging       Date:  2016-09-08       Impact factor: 1.930

6.  A Case of C5 Vertebral Chordoma in a 73-Year-Old Patient with More Than 8 Years of Follow-Up after Total Piecemeal Spondylectomy.

Authors:  Keigo Tanaka; Harutoshi Sakakima; Kazutoshi Hida; Kanako Hatanaka; Kosei Ijiri
Journal:  Case Rep Orthop       Date:  2017-09-12

7.  Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection.

Authors:  Wenhao Hu; Jiayi Yu; Yong Huang; Fanqi Hu; Xuesong Zhang; Yan Wang
Journal:  Transl Oncol       Date:  2018-02-22       Impact factor: 4.243

8.  Application of nomograms to predict overall and cancer-specific survival in patients with chordoma.

Authors:  Weipeng Zheng; Yuanping Huang; Tianwang Guan; Songfang Lu; Liquan Yao; Senrui Wu; Haoyi Chen; Ning Wang; YingJie Liang; Wende Xiao; Xin Jiang; Shifeng Wen
Journal:  J Bone Oncol       Date:  2019-06-24       Impact factor: 4.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.